National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

News & Events
 News Releases
 Qs & As
 Media Inquiries
 Events & Calendars
  Calendars
  Commemorative Days
  HIV Vaccine Awareness Day
  Meetings and Lectures
   2008 Kinyoun Lecture
   Polio Immunization
   Filovirus Workshop
   Ubiquitin Workshop
   Pediatric Tuberculosis
   Bioinformatics Summit 2008
   Mycobacteria Symposium
   CMSP Focused on Enteric Diseases
   US-Japan Viral Immunology Symposium
  Vaccine Research Seminars
 NIAID in the News
 Resources


Vaccines for Viral Infections in Developing Countries

Agenda

Thursday, July 27, 2006

8:50 AM Opening Remarks
Diane Griffin, Johns Hopkins University, USA
Harry Greenberg, Stanford University, USA
9:00 AM Overview and Major Issues for Assessment of Disease Burden of Viral Diseases in Asia
Hitoshi Oshitani, Tohoku University, Japan

Rotavirus Session

9:45 AM Epidemiology Of Rotavirus Infection And The Need For A Vaccine In Asia
Tony Nelson, The Chinese University of Hong Kong, China
10:15 AM Development and Implementation of Vaccine Made in the Third World
R. Bhan, New Delhi, India
10:45 AM Break
11:00 AM Outlook for the Implementation of a Human-Bovine (UK) Rotavirus Reassortant Vaccine
Al Kapikian, NIH, USA
11:30 AM
Development and Commercial Manufacturing Challenges for Live Attenuated Rotavirus Vaccines
W. Wainwright, Path and NIH, USA
12:00 PM Phase III Clinical Results of Rotavirus Vaccine Trials and Efforts to Accelerate Introduction to the Developing World
John Boslego, Path, USA
12:30 PM Lunch

Human Papillomavirus Session

1:30 PM Human Papillomavirus Vaccination for Cervical Cancer Prevention
Patti Gravitt, Johns Hopkins University, USA
2:00 PM Issues Regarding Marketing and Distribution of Vaccines in Developing Countries
Elaine Esber, Merck, USA
2:30 PM Development of Human Papillomavirus Vaccine Against a Broader Spectrum of Oncogenic Types
Tadahito Kanda, Japan

Rabiesvirus Session

3:00 PM Rabies Epidemiology, Disease Burden and Vaccine Utilization in Asia
Elizabeth Miranda, Phillipines
3:30 PM Break
3:45 PM Current Vaccines and Their Availability in China
Zhen Fu, University of Georgia, USA
4:15 PM
Control of Rabies in Asia Requires Quality Biologicals and the Motivation to Use Them Appropriately
Henry Wilde, Thai Red Cross
4:45 PM Adjourn
6:30-
8:30 PM
Reception


 

Friday, July 28, 2006


Japanese Encephalitis Session

9:00 AM Strategy for Introduction of JE Vaccine Into Routine Immunization
Julie Jacobson, Path, USA
9:30 AM     Disease Burden Due to Japanese Encephalitis (JE) and Cost-Effectiveness of JE Immunization in Asia
Zhi-Yi Xu, IVI, Seoul
10:00 AM Continued Transmission and Need for Booster Doses in An Endemic Country
Eiji Konishi, Kobe University, Japan
10:30 AM Break
10:45 AM

Immunological Surrogates for Japanese Encephalitis Vaccine-Induced Protection
Ichiro Kurane, NIH Japan

11:15 AM
Developing a New JE Vaccine–Switch the Mouse Brain to the Vero Cell
Shigeharu Ueda, BIKEN Foundation, Japan
11:45 AM Inactivated SA14-14-2
Erich Tauber, Intercell, AG
12:15 PM     Lunch
1:30 PM Safety and Efficacy of Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 in Human Vaccination
Yu Yongxin, NICBP, Beijing
2:00 PM ChimerivaxTM – A Platform Technology for Flavivirus Vaccine Development – Status of a New Vaccine Against Japanese Encephalitis 
Niranjan Kanesa-thasan, Acambis, USA

Influenza Session

2:30 PM Emergence and Continuing Evolution of H5N1 Influenza
Robert Webster, St. Jude Hospital, USA
3:00 PM Vaccine Development for Pandemic and Seasonal Influenza
John Treanor, University of Rochester Medical Center, USA
3:30 PM Break
3:45 PM Influenza in Asia
Hiroshi Suzuki, Niigata University, Japan
4:15 PM Influenza Virus Patterns in Asia
Mark Steinhoff, Johns Hopkins University, USA
4:45 PM Development Of Human Influenza H5N1 Vaccines In Japan: Research And Clinical Trials
Masato Tashiro, National Institute of Infectious Diseases, Japan
5:15 PM Closing Remarks
Akira Oya, National Institute of Infectious Diseases, Japan

Participant List (PDF)

 
E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.